Insmed Incorporated revenue for the last year amounted to 305.21 M USD, the most of which — 305.21 M USD — came from its highest performing source at the moment, Therapies, the year earlier bringing 245.36 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Insmed Incorporated 224.19 M USD, and the year before that — 185.99 M USD.